Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-26-044433
Filing Date
2026-04-16
Accepted
2026-04-16 11:04:56
Documents
1
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 13004
  Complete submission text file 0001213900-26-044433.txt   14415
Mailing Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402
Business Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402 97289406472
KAMADA LTD (Issuer) CIK: 0001567529 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address YIGAL ALON 94 STREET TEL AVIV Israel 00000
Business Address
Asher-Topilsky Lilach (Reporting) CIK: 0002128355 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35948 | Film No.: 26866193